Seelos Therapeutics Correlations

SEELDelisted Stock  USD 0.39  0.11  22.00%   
The current 90-days correlation between Seelos Therapeutics and Better Therapeutics is -0.07 (i.e., Good diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Seelos Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Seelos Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

Seelos Therapeutics Correlation With Market

Good diversification

The correlation between Seelos Therapeutics and DJI is -0.03 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Seelos Therapeutics and DJI in the same portfolio, assuming nothing else is changed.
  
The ability to find closely correlated positions to Seelos Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Seelos Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Seelos Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Seelos Therapeutics to buy it.

Moving together with Seelos OTC Stock

  0.7PTAIF PT Astra InternationalPairCorr
  0.63PTAIY Astra International TbkPairCorr
  0.88PKX POSCO Holdings Earnings Call This WeekPairCorr
  0.68PHJMF PT Hanjaya MandalaPairCorr

Moving against Seelos OTC Stock

  0.91AAL American Airlines Earnings Call This WeekPairCorr
  0.83SOUN SoundHound AIPairCorr
  0.82QBTS D Wave QuantumPairCorr
  0.81UAL United Airlines Holdings Earnings Call TomorrowPairCorr
  0.81PLTR Palantir Technologies Aggressive PushPairCorr
  0.76KODK Eastman KodakPairCorr
  0.75WMT WalmartPairCorr
  0.74WSM Williams SonomaPairCorr
  0.72MITQ Moving iMage TechnologiesPairCorr
  0.71OPFI OppFi IncPairCorr
  0.5ITCI Intracellular Th TrendingPairCorr
  0.46PAGP Plains GP Holdings Sell-off TrendPairCorr
  0.44BZUSD Brent Crude OilPairCorr
  0.38MCK McKessonPairCorr
  0.34PIFMY Indofood Sukses MakmurPairCorr
  0.32MOGO Mogo IncPairCorr
  0.91GOOGL Alphabet Class APairCorr
  0.88ZVIA Zevia PbcPairCorr
  0.87TSLA Tesla Inc Aggressive PushPairCorr
  0.86TATT Tat TechnoPairCorr
  0.86CLS CelesticaPairCorr
  0.85FWONK Liberty MediaPairCorr
  0.84JBL Jabil CircuitPairCorr
  0.84ACHR Archer AviationPairCorr
  0.79AVGO Broadcom Aggressive PushPairCorr
  0.79FSK FS KKR CapitalPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
AKTXCAPR
DFFNAWKNF
DFFNCAPR
CAPRAWKNF
DFFNAKTX
AWKNFCYBN
  
High negative correlations   
AKTXPULM
CAPRPULM
DFFNPULM
FRLNMNMD
PULMFRLN
PULMAWKNF

Risk-Adjusted Indicators

There is a big difference between Seelos OTC Stock performing well and Seelos Therapeutics OTC Stock doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Seelos Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
ATAI  4.90  0.61  0.11  3.08  4.79 
 12.06 
 28.12 
MNMD  4.33  0.45  0.09  0.82  4.83 
 9.92 
 25.72 
GHRS  3.66  0.43  0.08 (4.92) 4.79 
 9.01 
 26.47 
FRLN  5.90 (0.12) 0.00 (0.09) 0.00 
 14.23 
 72.38 
CYBN  3.65 (0.02)(0.01)(0.01) 4.10 
 9.19 
 24.94 
AWKNF  4.11  0.00  0.00  0.02  0.00 
 15.50 
 43.08 
PULM  5.87  2.20  0.41 (1.06) 4.12 
 16.69 
 92.85 
CAPR  4.08 (0.40) 0.00 (0.38) 0.00 
 9.07 
 33.27 
AKTX  5.39 (0.87) 0.00  1.08  0.00 
 10.68 
 47.27 
DFFN  2.40 (0.51) 0.00  1.66  0.00 
 4.09 
 12.34 

View Seelos Therapeutics Related Equities

 Risk & Return  Correlation

Seelos Therapeutics Corporate Management

Elected by the shareholders, the Seelos Therapeutics' board of directors comprises two types of representatives: Seelos Therapeutics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Seelos. The board's role is to monitor Seelos Therapeutics' management team and ensure that shareholders' interests are well served. Seelos Therapeutics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Seelos Therapeutics' outside directors are responsible for providing unbiased perspectives on the board's policies.
Gopal KrishnaHead OperationsProfile
Michael GolembiewskiChief OfficerProfile
Kimberly FarrandSenior OperationsProfile
Raj JDChairman, FounderProfile
Anthony MarcianoChief OfficerProfile
Karen FusaroSenior OperationsProfile
Tim MDChief OfficerProfile

Still Interested in Seelos Therapeutics?

Investing in delisted otcs can be risky, as the otc stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.